170 related articles for article (PubMed ID: 4690469)
1. Keeping bioavailability in perspective.
Schumacher GE
Am J Hosp Pharm; 1973 Feb; 30(2):150-4. PubMed ID: 4690469
[No Abstract] [Full Text] [Related]
2. An overview of the analysis and interpretation of bioavailability studies in man.
Wagner JG
Pharmacology; 1972; 8(1):102-17. PubMed ID: 4644642
[No Abstract] [Full Text] [Related]
3. Bioavailability of drugs (first of two parts).
Koch-Weser J
N Engl J Med; 1974 Aug; 291(5):233-7. PubMed ID: 4600408
[No Abstract] [Full Text] [Related]
4. Partitioning phenomena in dosage form and biopharmaceutical design. 3. Some partitioning considerations in drug absorption, distribution, response and elimination.
Schumacher GE
Am J Hosp Pharm; 1972 Apr; 29(4):339-43. PubMed ID: 5025265
[No Abstract] [Full Text] [Related]
5. Therapeutic non-equivalence.
Br Med J; 1972 Sep; 3(5827):599-600. PubMed ID: 5071688
[No Abstract] [Full Text] [Related]
6. Bioavailability of drugs: principles and problems. Report of a WHO Scientific Group.
World Health Organ Tech Rep Ser; 1973 Nov; 536():1-17. PubMed ID: 4204708
[No Abstract] [Full Text] [Related]
7. [A pharmacokinetic function for galenics].
Dost FH
Arzneimittelforschung; 1971 May; 21(5):712-7. PubMed ID: 5109699
[No Abstract] [Full Text] [Related]
8. [Influence of the starting materials on bioavailability of drugs].
Bagnaresi P; Bulgarelli D; Calvi A; Ferrarini G
Boll Chim Farm; 1973 Feb; 112(2):83-93. PubMed ID: 4719968
[No Abstract] [Full Text] [Related]
9. [Pharmacokinetic models].
Dahl S
Tidsskr Nor Laegeforen; 1973 Jan; 93(3):157-62. PubMed ID: 4693373
[No Abstract] [Full Text] [Related]
10. Bioavailability: some pharmaceutical factors.
Fowle AS
Trans Med Soc Lond; 1975; 91():23-32. PubMed ID: 1236035
[No Abstract] [Full Text] [Related]
11. Non-equivalence of digoxin tablets.
Reissell P; Manninen V; Ojala K; Karjalainen J
Ann Clin Res; 1974; 6(0):suppl 11:4-8. PubMed ID: 4853359
[No Abstract] [Full Text] [Related]
12. Bioavailability of drugs (second of two parts).
Koch-Weser J
N Engl J Med; 1974 Sep; 291(10):503-6. PubMed ID: 4604153
[No Abstract] [Full Text] [Related]
13. [Pharmacokinetic methods for the evaluation of intestinal absorption].
Kübler W
Z Kinderheilkd; 1970; 108(3):187-96. PubMed ID: 5475029
[No Abstract] [Full Text] [Related]
14. Proceedings: The line-up on bioavailability.
Schneller GH
Rev Can Biol; 1973; 32():Suppl:151-5. PubMed ID: 4777598
[No Abstract] [Full Text] [Related]
15. Bioavailability of digoxin tablets.
Lindenbaum J
Pharmacol Rev; 1973 Jun; 25(2):229-37. PubMed ID: 4581042
[No Abstract] [Full Text] [Related]
16. [Methodological approach to the measure of the bioavailability of drugs in man (author's transl)].
Lesne M
J Pharm Belg; 1976; 31(1):5-24. PubMed ID: 768445
[No Abstract] [Full Text] [Related]
17. Some aspects of the influence of formulation on the bioavailability of drugs from solid dosage forms.
Corrigan OI; Timoney RF
Ir J Med Sci; 1974 Jul; 143(4):197-207. PubMed ID: 4605123
[No Abstract] [Full Text] [Related]
18. Novel method for bioavailability assessment.
Kwan KC; Till AE
J Pharm Sci; 1973 Sep; 62(9):1494-7. PubMed ID: 4743100
[No Abstract] [Full Text] [Related]
19. Bioavailability and digoxin.
N Z Med J; 1972 Sep; 76(484):203. PubMed ID: 4508750
[No Abstract] [Full Text] [Related]
20. Classical bioavailability methods: blood levels and urinary excretion.
Dittert LW
Psychopharmacol Bull; 1976 Oct; 12(4):54-5. PubMed ID: 972991
[No Abstract] [Full Text] [Related]
[Next] [New Search]